Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor Model

ObjectivesTo discriminate viable tumors from benign periablational enhancement (BPE) in early stage after radiofrequency ablation (RFA) is a major confounding problem. The goal of this study is to evaluate quantitative assessment and diagnostic value of CT perfusion between viable tumors and BPE aft...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaofei Yue, Xiangjun Dong, Mengting Huang, Hongli Yang, Kun Qian, Changhong Yi, Osamah Alwalid, Yanqiao Ren, Ping Han, Qian Li
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
HCC
Acceso en línea:https://doaj.org/article/b42775d8816f483ab07d5e6fecbcd9d9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b42775d8816f483ab07d5e6fecbcd9d9
record_format dspace
spelling oai:doaj.org-article:b42775d8816f483ab07d5e6fecbcd9d92021-12-01T01:53:59ZEarly Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor Model2234-943X10.3389/fonc.2021.728781https://doaj.org/article/b42775d8816f483ab07d5e6fecbcd9d92021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.728781/fullhttps://doaj.org/toc/2234-943XObjectivesTo discriminate viable tumors from benign periablational enhancement (BPE) in early stage after radiofrequency ablation (RFA) is a major confounding problem. The goal of this study is to evaluate quantitative assessment and diagnostic value of CT perfusion between viable tumors and BPE after RFA in the rabbit liver VX2 tumor model, with pathological results as the standard.MethodsTwenty-eight VX2 liver tumors were treated with RFA, on days 1, 3, 7, and 14, seven rabbits were randomly chosen for CT perfusion and performed pathology examinations immediately. The perfusion parameters along with the profile of time-density curves (TDCs) and pseudo-color images of the parameters were observed in both BPE and viable tumors, then compared with the pathology results. The perfusion parameters included blood flow (BF), blood volume (BV), time to peak (TTP), permeability (P), arterial liver perfusion (ALP), portal venous perfusion (PVP) and hepatic perfusion index (HPI).ResultsA total of 26/28 rabbits successfully underwent CT perfusion, while 6/26 lesions were confirmed to be viable tumors. The TDCs of BPE were mainly speed-up platform curves (15/26), while the viable tumors showed mainly speed-up speed-down (3/6) and speed-up platform (2/6) curves. The PVP values were significantly higher, and the HPI values were significantly lower for BPE at all time points than viable tumors (P < 0.05). Both of PVP value and HPI value have high efficiency for the differential diagnosis of the viable tumors and BPE at each time point. These characteristics of CT perfusion parameters were consistent with pathological changes.ConclusionsThe TDCs, PVP and HPI have the potential to indicate BPE and viable tumors effectively early after RFA treatment, the results were highly consistent with pathology. CT perfusion has advantages with great efficacy in monitoring the therapeutic effect early after RFA treatment.Xiaofei YueXiaofei YueXiangjun DongXiangjun DongMengting HuangMengting HuangHongli YangHongli YangKun QianKun QianChanghong YiOsamah AlwalidOsamah AlwalidYanqiao RenYanqiao RenPing HanPing HanQian LiQian LiFrontiers Media S.A.articleradiofrequency ablationHCCcomputed tomographyCT perfusion imagesVX2 tumor modelsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic radiofrequency ablation
HCC
computed tomography
CT perfusion images
VX2 tumor models
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle radiofrequency ablation
HCC
computed tomography
CT perfusion images
VX2 tumor models
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Xiaofei Yue
Xiaofei Yue
Xiangjun Dong
Xiangjun Dong
Mengting Huang
Mengting Huang
Hongli Yang
Hongli Yang
Kun Qian
Kun Qian
Changhong Yi
Osamah Alwalid
Osamah Alwalid
Yanqiao Ren
Yanqiao Ren
Ping Han
Ping Han
Qian Li
Qian Li
Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor Model
description ObjectivesTo discriminate viable tumors from benign periablational enhancement (BPE) in early stage after radiofrequency ablation (RFA) is a major confounding problem. The goal of this study is to evaluate quantitative assessment and diagnostic value of CT perfusion between viable tumors and BPE after RFA in the rabbit liver VX2 tumor model, with pathological results as the standard.MethodsTwenty-eight VX2 liver tumors were treated with RFA, on days 1, 3, 7, and 14, seven rabbits were randomly chosen for CT perfusion and performed pathology examinations immediately. The perfusion parameters along with the profile of time-density curves (TDCs) and pseudo-color images of the parameters were observed in both BPE and viable tumors, then compared with the pathology results. The perfusion parameters included blood flow (BF), blood volume (BV), time to peak (TTP), permeability (P), arterial liver perfusion (ALP), portal venous perfusion (PVP) and hepatic perfusion index (HPI).ResultsA total of 26/28 rabbits successfully underwent CT perfusion, while 6/26 lesions were confirmed to be viable tumors. The TDCs of BPE were mainly speed-up platform curves (15/26), while the viable tumors showed mainly speed-up speed-down (3/6) and speed-up platform (2/6) curves. The PVP values were significantly higher, and the HPI values were significantly lower for BPE at all time points than viable tumors (P < 0.05). Both of PVP value and HPI value have high efficiency for the differential diagnosis of the viable tumors and BPE at each time point. These characteristics of CT perfusion parameters were consistent with pathological changes.ConclusionsThe TDCs, PVP and HPI have the potential to indicate BPE and viable tumors effectively early after RFA treatment, the results were highly consistent with pathology. CT perfusion has advantages with great efficacy in monitoring the therapeutic effect early after RFA treatment.
format article
author Xiaofei Yue
Xiaofei Yue
Xiangjun Dong
Xiangjun Dong
Mengting Huang
Mengting Huang
Hongli Yang
Hongli Yang
Kun Qian
Kun Qian
Changhong Yi
Osamah Alwalid
Osamah Alwalid
Yanqiao Ren
Yanqiao Ren
Ping Han
Ping Han
Qian Li
Qian Li
author_facet Xiaofei Yue
Xiaofei Yue
Xiangjun Dong
Xiangjun Dong
Mengting Huang
Mengting Huang
Hongli Yang
Hongli Yang
Kun Qian
Kun Qian
Changhong Yi
Osamah Alwalid
Osamah Alwalid
Yanqiao Ren
Yanqiao Ren
Ping Han
Ping Han
Qian Li
Qian Li
author_sort Xiaofei Yue
title Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor Model
title_short Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor Model
title_full Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor Model
title_fullStr Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor Model
title_full_unstemmed Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor Model
title_sort early assessment of response to radiofrequency ablation with ct perfusion imaging in rabbit vx2 liver tumor model
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/b42775d8816f483ab07d5e6fecbcd9d9
work_keys_str_mv AT xiaofeiyue earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT xiaofeiyue earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT xiangjundong earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT xiangjundong earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT mengtinghuang earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT mengtinghuang earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT hongliyang earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT hongliyang earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT kunqian earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT kunqian earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT changhongyi earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT osamahalwalid earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT osamahalwalid earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT yanqiaoren earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT yanqiaoren earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT pinghan earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT pinghan earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT qianli earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
AT qianli earlyassessmentofresponsetoradiofrequencyablationwithctperfusionimaginginrabbitvx2livertumormodel
_version_ 1718405982004969472